Supplement: Nonmedication Therapies

Nonmedication Therapies By Anne Harding Cognitive behavioral therapy, transcranial magnetic stimulation may play a role in treatment ARTICLE EXTRAS The Treatments A Troubled History First-Generation Antipsychotic Drugs The Atypical Atypical? The next generation? The Lessons of CATIE Second-Generation Antipsychotic Drugs Beyond Drugs Cognitive behavioral therapy (CBT) is increasingly being recognized as a helpful approach for people with schizophren

Written byAnne Harding
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Treatments

A Troubled History

First-Generation Antipsychotic Drugs

The Atypical Atypical?

The next generation?

The Lessons of CATIE

Second-Generation Antipsychotic Drugs

Beyond Drugs

Cognitive behavioral therapy (CBT) is increasingly being recognized as a helpful approach for people with schizophrenia. Widely used to help people manage harmful habits, thoughts, and behaviors, CBT can be particularly useful in addressing schizophrenia symptoms that medication hasn't alleviated. For example, explains Anthony Lehman, chair of the Department of Psychiatry at the University of Maryland in Baltimore, CBT can be useful for a person who experiences paranoid thoughts that people are staring at them and talking about them when they get on a bus. "CBT can help them learn to cope with those kinds of ideas and essentially learn to do a reality test on those ideas so they don't interfere with their daily life," Lehman explains. Then they can ride the bus to work or ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies